Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel
Scientists create synthetic form of SBV
Schmallenberg study raises vaccine hopes

Scottish scientists have made a synthetic version of the Schmallenberg virus (SBV) in the laboratory, raising hopes for the development of a vaccine for the disease.

The synthetic version was formed so that scientists were able to study its genetics and how it infects farm animals. They manipulated the virus's genetic sequence so it was more and less severe during the study.

Experiments showed that, if the virus is passed to calves or lambs during pregnancy, it replicates itself in the brain cells and spinal cords of the unborn animals.

Massimo Palmarini and Alan Kohl led the study at the MRC-University of Glasgow Centre for Virus Research.

Professor Palmarini said: "This is the first time we have been able to manipulate the genome of SBV in this way. We now know much more about how the virus causes the disease than we did a couple of months ago."

SBV was first discovered in Germany in November 2011 and has since spread to the UK, via midges that were blown over from the continent. The virus is now carried by native midges, and has affected about 1,000 farms across England and Wales.

An SBV vaccine is currently undergoing tests for European approval.

Become a member or log in to add this story to your CPD history

FIVP launches CMA remedies survey

News Story 1
 FIVP has shared a survey, inviting those working in independent practice to share their views on the CMA's proposed remedies.

The Impact Assessment will help inform the group's response to the CMA, as it prepares to submit further evidence to the Inquiry Group. FIVP will also be attending a hearing in November.

Data will be anonymised and used solely for FIVP's response to the CMA. The survey will close on Friday, 31 October 2025. 

Click here for more...
News Shorts
CMA to host webinar exploring provisional decisions

The Competition and Markets Authority (CMA) is to host a webinar for veterinary professionals to explain the details of its provisional decisions, released on 15 October 2025.

The webinar will take place on Wednesday, 29 October 2025 from 1.00pm to 2.00pm.

Officials will discuss the changes which those in practice may need to make if the provisional remedies go ahead. They will also share what happens next with the investigation.

The CMA will be answering questions from the main parties of the investigation, as well as other questions submitted ahead of the webinar.

Attendees can register here before Wednesday, 29 October at 11am. Questions must be submitted before 10am on 27 October.

A recording of the webinar will be accessible after the event.